Monday, November 30, 2020

Glenmark Pharma gets tentative nod from USFDA for cancer treatment drug

Glenmark Pharma gets tentative nod from USFDA for cancer treatment drug The tentatively approved product is the generic version of Inlyta tablets of PF Prism CV.

from Moneycontrol Business News https://ift.tt/33u15rC

No comments:

Post a Comment

Weekly Expiry: Sensex mirrors Nifty's swings, but with milder spurts

The recent weekly expiry of Sensex showcased unexpected surges in the index and heightened options premiums. Traders observe that such fluct...